Russian researchers from Tomsk and Novosibirsk developed a basic substance for future treating agent for liver regeneration during cirrhosis.

      Liver cirrhosis is a severe disease, which is among ten most common death causes in patients from developed countries. During cirrhosis healthy liver tissue transforms into connective tissue, which results in liver failure.

      New substance is an immobilized enzyme, which activates liver cells and makes them replace connective tissue with healthy liver tissue. Existing liver treating agents protect healthy cells, but not a single substance was able to replace connective tissue with healthy one.

      The substance is currently under preclinical trials.

      Source: RIA Novosti